Loach A B, Young A C, Spalding J M, Smith A C
Br Med J. 1975 Feb 8;1(5953):309-12. doi: 10.1136/bmj.1.5953.309.
This paper reports a retrospective study of the preoperative and postoperative management of 28 patients who underwent thymectomy between 1956 and 1973. Patients who received postoperative artificial ventilation were compared with the group who did not with respect to sex, age, severity of disease, preoperative vital capacity, and thymic histology. Evidence is presented that postoperative artificial ventilation is required when the preoperative vital capacity with the patient on optimum anticholinesterase treatment is less than 2 litres. Additional features associated with a probable need for artificial ventilation were the presence of a thymoma, bulbar symptoms, especially dysphagia, and age over 50 years. These should be taken into account in any patient whose vital capacity is close to the critical level of 2 litres. When postoperative ventilation was required it was usually necessary for 12 days or more, and tracheostomy should therefore be done at or before thymectomy. Most patients in this series received the same dose of anticholinesterases after operation as before it and no evidence was found of a sudden decrease in requirements for anticholinesterase therapy. Two patients did not, and in them a myasthenic crisis was precipitated. We propose that the preoperative drug regimen can be continued in the immediate postthymectomy period, allowing selection of patients for tracheostomy and artificial ventilation primarily on the basis of the preoperative vital capacity.
本文报告了一项对1956年至1973年间接受胸腺切除术的28例患者术前和术后管理的回顾性研究。将接受术后人工通气的患者与未接受人工通气的患者在性别、年龄、疾病严重程度、术前肺活量和胸腺组织学方面进行了比较。有证据表明,当患者在最佳抗胆碱酯酶治疗下术前肺活量小于2升时,需要进行术后人工通气。与可能需要人工通气相关的其他特征包括存在胸腺瘤、延髓症状,尤其是吞咽困难,以及年龄超过50岁。对于任何肺活量接近2升临界水平的患者都应考虑这些因素。当需要术后通气时,通常需要12天或更长时间,因此应在胸腺切除术时或之前进行气管切开术。该系列中的大多数患者术后接受的抗胆碱酯酶剂量与术前相同,未发现抗胆碱酯酶治疗需求突然减少的证据。有两名患者并非如此,他们引发了重症肌无力危象。我们建议在胸腺切除术后的即刻可以继续术前的药物治疗方案,主要根据术前肺活量来选择进行气管切开术和人工通气的患者。